Herpes simplex virus vaccine - VAXXITAlternative Names: HSV-1 vaccine - VAXXIT; HSV-2 vaccine - VAXXIT
Latest Information Update: 11 May 2016
At a glance
- Originator VAXXIT
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus infections
Most Recent Events
- 10 May 2016 Preclinical trials in Herpes simplex virus infections in Italy (unspecified route) (VAXXIT website)